Search

Across the United States, there is a disparity in the rate of people who are candidates for a partial nephrectomy — those with small renal tumors — and those who actually have the procedure.

… Wednesday, April 18, 2018 Across the United States, there is a disparity in the rate of people who are candidates for a partial nephrectomy — those with small renal tumors — and those who actually have the procedure. Research shows that this is mainly because the operation is challenging and associated

Researchers identify a biomarker that could predict which lung cancer patients will respond to chemotherapy.

… Tuesday, October 26, 2021 Lung adenocarcinoma, the most common form of  lung cancer  in the United States, can be difficult to cure unless diagnosed at an early stage. Surgery is effective at removing early-stage tumors, but more than half of patients with stage 2 or 3 disease have a recurrence of their

New MSK research uses cryo-electron microscopy to shed new light on the ubiquitin; could help predict the risk of blood clots in cancer patients; reveals why micronuclei burst, accelerating aggressive cancers; and surveys healthcare providers about the benefits and risks of commercial genetic testing.

… Tuesday, September 3, 2024 New research from Memorial Sloan Kettering Cancer Center (MSK) uses cryo-electron microscopy to shed new light on the ubiquitin; could help predict the risk of blood clots in cancer patients; reveals why micronuclei burst, accelerating aggressive cancers; and surveys healthcare

… Tuesday, July 1, 2014 Neurosurgeon Mark Bilsky , received the Willet F. Whitmore Award for Clinical Excellence at the 2014 Academic Convocation ceremony and Commencement for students from the Louis V. Gerstner Graduate School of Biomedical Sciences. The annual award is presented to a clinician whose

Human papillomavirus (HPV)–associated oropharyngeal cancer is on the rise, but at Memorial Sloan Kettering Cancer Center, we have updated our standard of care to substantially reduce the radiation dose to elective regions.

… Tuesday, December 10, 2019 Human papillomavirus (HPV)–associated oropharyngeal cancer is on the rise, but at Memorial Sloan Kettering Cancer Center, we have updated our standard of care to substantially reduce the radiation dose to elective regions. In our paper, published recently in the journal Practical

MSK gastroenterologist Robin Mendelsohn weighs in on the possible benefits and drawbacks of using aspirin to reduce the risk of colon and rectal cancer.

… Tuesday, March 21, 2017 Summary In this Q&A, MSK gastroenterologist Robin Mendelsohn weighs in on the possible benefits and drawbacks of using aspirin to reduce the risk of colon cancer and rectal cancer. Colorectal cancer is the third most common cancer in the United States for both men and women, excluding

Memorial Sloan Kettering Cancer Center (MSK) is the first academic research institution worldwide to join a major global initiative focused on revolutionizing clinical trial administration.

… Tuesday, December 17, 2024 Memorial Sloan Kettering Cancer Center (MSK) is the first academic research institution worldwide to join a major global initiative focused on revolutionizing clinical trial administration. The i-HD eSource Scale Up Task Force, led by the European Institute for Innovation through

Sloan Kettering Institute Structural Biology Program Chair Dr. Christopher Lima was elected to the 2025 class of American Association for the Advancement of Science Fellows.

… Tuesday, April 14, 2026 Christopher D. Lima, PhD , Chair of the Structural Biology Program at the Sloan Kettering Institute and a Howard Hughes Medical Institute Investigator was named a 2025 Honorary Fellow of the  American Association for the Advancement of Science  — one of the world’s largest scientific

Uterine-preserving surgery results in excellent and similar five-year disease-specific survival compared to hysterectomy in young women with stage IB1 cervical cancer.

… Monday, January 14, 2019 Uterine-preserving surgery results in excellent and similar five-year disease-specific survival compared to hysterectomy in young women with stage IB1 cervical cancer , especially in women with smaller tumors, according to our recent research. The retrospective study is one of

Treatment with chimeric antigen receptor T cell therapy should proceed in patients with B cell non-Hodgkin lymphomas and B cell acute lymphocytic leukemia, despite Covid-19 according to the CAR T Cell Consortium, a collaboration of investigators from eight U.S. academic institutions.

… Monday, May 11, 2020 Treatment with chimeric antigen receptor T cell therapy should proceed in patients with B cell non-Hodgkin lymphomas and B cell acute lymphocytic leukemia, despite the challenges of Covid-19, according to the CAR T Cell Consortium, a collaboration of investigators from eight U.S.